Patents by Inventor Xaoxing S. Xu

Xaoxing S. Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antisense modulation of expression of tumor necrosis factor receptor-associated factors (TRAFs)
    Publication number: 20030055015
    Abstract: Compositions and methods are provided for modulating the expression of tumor necrosis factor receptor-assocaited factor (TRAF). Antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding TRAF are preferred. Methods of using these compounds for modulation of TRAF expression and for treatment of diseases associated with expression of TRAF are provided.
    Type: Application
    Filed: February 4, 2002
    Publication date: March 20, 2003
    Inventors: Brenda F. Baker, Lex M. Cowsert, Brett P. Monia, Xaoxing S. Xu
  • Antisense modulation of expression of tumor necrosis factor receptor-associated factors (TRAFs)
    Patent number: 6399297
    Abstract: Compositions and methods are provided for modulating the expression of tumor necrosis factor receptor-associated factor (TRAF). Antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding TRAF are preferred. Methods of using these compounds for modulation of TRAF expression and for treatment of diseases associated with expression of TRAF are provided.
    Type: Grant
    Filed: October 6, 1998
    Date of Patent: June 4, 2002
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Brenda F. Baker, Lex M. Cowsert, Brett P. Monia, Xaoxing S. Xu